BINV — BioInvent International AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK1.93bn
- SEK1.08bn
- SEK44.69m
Annual cashflow statement for BioInvent International AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -75.5 | -278 | -50.9 | -370 | -471 |
| Depreciation | |||||
| Non-Cash Items | -0.041 | 1.14 | 1.79 | 2.95 | 5.46 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.889 | 16.8 | -5.94 | 11.9 | 65.7 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -62.6 | -246 | -40.3 | -338 | -381 |
| Capital Expenditures | -6.7 | -13.3 | -12.4 | -13.3 | -10 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -454 | -616 | 73 | 574 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -6.7 | -468 | -629 | 59.7 | 564 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 645 | 895 | 273 | 23.1 | -8.46 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 575 | 181 | -396 | -255 | 175 |